NCT01132053View on ClinicalTrials.gov

Role of Inflammation in Progressive Multifocal Leukoencephalopathy (PML)

CompletedOBSERVATIONAL
Enrollment

126

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

September 30, 2016

Study Completion Date

December 31, 2018

Conditions
Progressive Multifocal Leukoencephalopathy
Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Beth Israel Deaconess Medical Center

OTHER

NCT01132053 - Role of Inflammation in Progressive Multifocal Leukoencephalopathy (PML) | Biotech Hunter | Biotech Hunter